Inhibition of “insulin secretion”, “fatty acid metabolism”, and “maturity-onset diabetes of the young” was again observed between “T2D and T1D” (Figure S4B), in keeping with disease-specific target tissue dysfunction. The gene discussed is INS; the disease is type 2 diabetes mellitus.